by Jordana Choucair | Aug 5, 2022 | Life Sciences
PhRMA and its 31 board members sent a letter to every member of Congress yesterday imploring them to vote against Democrats’ reconciliation package. PhRMA CEO Steve Ubl said in an interview that lawmakers “who vote for this bill will not get a free...
by Jordana Choucair | Aug 5, 2022 | Life Sciences
Amgen Inc. secured a deal to buy ChemoCentryx Inc. for $3.7 billion, giving the biotech company access to the potential blockbuster drug Tavneos. The drug is used to treat patients with a rare type of blood vessel inflammation that generated $5.4 million in sales in...
by Jordana Choucair | Aug 5, 2022 | M&A
MedArrive, a home-based health care technology company, and Brave Health, a virtual-first behavioral health provider, have partnered to enable Medicaid patients to access behavioral health services from their homes. Through the partnership, MedArrive will refer...
by Jordana Choucair | Aug 5, 2022 | Opioid/Substance Use Disorders
Tennessee Attorney General Herbert Slatery III filed a lawsuit accusing Walgreens of creating a public nuisance by illegally selling and distributing opioids. According to Slatery, Walgreens dispensed more than 1.1 billion opioid prescriptions to the state’s 7...
by Jordana Choucair | Aug 5, 2022 | Providers
The American Hospital Association (AHA) filed several motions asking a district court to examine how the Centers for Medicare & Medicaid Services (CMS) plans to repay hospitals for 340B payment cuts. The AHA argued that hospitals that weren’t affected by...
Recent Comments